Page last updated: 2024-08-23

tetradecanoylphorbol acetate and shogaol

tetradecanoylphorbol acetate has been researched along with shogaol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chew, EH; Chui, WK; Ling, H; Tan, SH; Yang, H1
Cho, HJ; Han, NY; Jung, HS; Lee, MJ; Sohn, Y1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and shogaol

ArticleYear
6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation.
    British journal of pharmacology, 2010, Volume: 161, Issue:8

    Topics: Antineoplastic Agents; Breast Neoplasms; Catechols; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Secreted; Neoplasm Invasiveness; NF-kappa B; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Zingiber officinale

2010
[6]-Shogaol inhibits the production of proinflammatory cytokines via regulation of NF-κB and phosphorylation of JNK in HMC-1 cells.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:4

    Topics: Animals; Calcimycin; Calcium Ionophores; Carcinogens; Catechols; Cell Line; Cytokines; Histamine Release; Humans; Inflammation; Male; MAP Kinase Kinase 4; Mast Cells; Mutagens; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate

2013